Arrowhead Pharmaceuticals, Inc. (ARWR)
41.41
-2.24
(-5.13%)
USD |
NASDAQ |
Nov 20, 16:00
41.41
0.00 (0.00%)
After-Hours: 19:22
Arrowhead Pharmaceuticals Gross Profit (TTM) : 422.57M for Sept. 30, 2026
Gross Profit (TTM) Chart
Historical Gross Profit (TTM) Data
| Date | Value |
|---|---|
| September 30, 2026 | 422.57M |
| June 30, 2026 | 643.69M |
| March 31, 2026 | 596.64M |
| December 31, 2025 | 1.066B |
| September 30, 2025 | 805.52M |
| June 30, 2025 | 550.41M |
| March 31, 2025 | 524.08M |
| December 31, 2024 | -17.07M |
| September 30, 2024 | -15.04M |
| June 30, 2024 | 2.219M |
| March 31, 2024 | 19.55M |
| December 31, 2023 | 167.67M |
| September 30, 2023 | 228.24M |
| June 30, 2023 | 244.92M |
| March 31, 2023 | 262.18M |
| December 31, 2022 | 267.80M |
| September 30, 2022 | 232.81M |
| June 30, 2022 | 203.90M |
| March 31, 2022 | 174.09M |
| December 31, 2021 | 24.87M |
| September 30, 2021 | 0.00 |
| June 30, 2021 | 0.00 |
| March 31, 2021 | 0.00 |
| December 31, 2020 | 0.00 |
| September 30, 2020 | 0.00 |
| Date | Value |
|---|---|
| June 30, 2020 | 0.00 |
| March 31, 2020 | 0.00 |
| December 31, 2019 | 0.00 |
| September 30, 2019 | 0.00 |
| June 30, 2019 | 0.00 |
| March 31, 2019 | 0.00 |
| December 31, 2018 | 0.00 |
| September 30, 2018 | 0.00 |
| June 30, 2018 | 0.00 |
| March 31, 2018 | 0.00 |
| December 31, 2017 | 0.00 |
| September 30, 2017 | 0.00 |
| June 30, 2017 | 0.00 |
| March 31, 2017 | 0.00 |
| December 31, 2016 | 0.00 |
| September 30, 2016 | 0.00 |
| June 30, 2016 | 0.00 |
| March 31, 2016 | 0.00 |
| December 31, 2015 | 0.00 |
| September 30, 2015 | 0.00 |
| June 30, 2015 | 0.00 |
| March 31, 2015 | 0.00 |
| December 31, 2014 | 0.00 |
| September 30, 2014 | 0.00 |
| June 30, 2014 | 0.00 |
Gross Profit Definition
Annual, Interim and Preliminary Items - Commercial, Other Financial Companies
Gross Profit (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit (TTM) Benchmarks
| Ionis Pharmaceuticals, Inc. | 915.88M |
| Alnylam Pharmaceuticals, Inc. | 3.874B |
| Nektar Therapeutics | 51.52M |
| Vertex Pharmaceuticals, Inc. | 11.15B |
| TG Therapeutics, Inc. | 742.84M |